Thomas Glanzmann
- Position: Non-executive Chairman
- Type: Other external
- First appointment: 05/04/06
- Re-elections: 24/05/11 - 27/05/16 - 09/10/20
- Last appointment: 09/10/20
Mr. Thomas H. Glanzmann has served as director of Grifols, S.A. since April 2006 and currently he is the Non-Executive Chairman of the Company. He also served as Grifols’ CEO from 8 May, 2023 up to April 1, 2024. From 2006 until 2011 he was the Chief Executive Officer and President of Gambro AB. Previously, Mr. Glanzmann was the CEO and Managing Director of HemoCue AB. Between 1988 and 2004 he held various positions at Baxter Healthcare Corporation: Senior VicePresident and Senior Corporate Officer of Baxter Healthcare Corporation, President of Baxter Bioscience, Chief Executive Officer of Immuno International; and President of the European Biotech Group, among others. Between 1984 and 1988, he worked at Philip Morris becoming country manager for Norway, Denmark and Iceland.
He holds a B.A. degree in Political Science from Dartmouth College, United States, and an M.B.A. from IMD, Lausanne – Switzerland. He also holds a Board of Directors Certification from the UCLA Anderson School of Management, USA.
He is a member of several committees at Alcon, Inc. (among others, the sustainability, compensation and innovation committee). He is a Founder and General Partner of Medical Technology Venture Partners in California, United States.